发明授权
US08758757B2 Humanized antibodies to interferon alpha receptor-1 (IFNAR-1)
失效
干扰素α受体-1（IFNAR-1）的人源化抗体
- 专利标题： Humanized antibodies to interferon alpha receptor-1 (IFNAR-1)
- 专利标题（中）： 干扰素α受体-1（IFNAR-1）的人源化抗体
-
申请号： US12972813申请日： 2010-12-20
-
公开(公告)号： US08758757B2公开(公告)日： 2014-06-24
- 发明人: Josephine M. Cardarelli , Tseng-hui Timothy Chen , David King , Christopher R. Bebbington , Sarah Lee Pogue , Francis J. Carr , Stephen Williams
- 申请人： Josephine M. Cardarelli , Tseng-hui Timothy Chen , David King , Christopher R. Bebbington , Sarah Lee Pogue , Francis J. Carr , Stephen Williams
- 申请人地址： US NJ Princeton
- 专利权人： Medarex, L.L.C.
- 当前专利权人： Medarex, L.L.C.
- 当前专利权人地址： US NJ Princeton
- 代理机构： Baker Botts L.L.P.
- 主分类号： A61K39/395
- IPC分类号： A61K39/395 ; C07K16/28 ; A61K39/00
摘要：
Humanized monoclonal antibodies which bind to IFNAR-1, and related antibody-based compositions and molecules, are disclosed. Also disclosed are pharmaceutical compositions comprising the humanized antibodies and therapeutic and diagnostic methods for using the humanized antibodies.
公开/授权文献
信息查询
